Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor.

导出 LinkOut

翻译打印收藏纠错

作者： Virginia J,Savin ^[1] ; Mukut,Sharma ^[2] ; Jianping,Zhou ^[1] ; David,Genochi ^[2] ; Ram,Sharma ^[1] ; Tarak,Srivastava ^[1] ; Amna,Ilahe ^[1] ; Pooja,Budhiraja ^[1] ; Aditi,Gupta ^[3] ; Ellen T,McCarthy ^[2]

作者单位： Renal Research Laboratory, Research and Development, MBRF and Kansas City VA Medical Center, Kansas City, MO, USA. ^[1] Kidney Institute, University of Kansas Medical Center, Kansas City, KS, USA. ^[2] Section of Nephrology, Children's Mercy Hospital and University of Missouri at Kansas City, Kansas City, MO, USA. ^[3]

主题词动物(Animals);细胞因子类(Cytokines);肾小球硬化症, 局灶节段性(Glomerulosclerosis, Focal Segmental);人类(Humans);Janus激酶2(Janus Kinase 2);肾小球(Kidney Glomerulus);通透性(Permeability);受体, 细胞因子(Receptors, Cytokine)

DOI 10.1155/2017/6232616

PMID 28951873

发布时间 2018-11-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

BioMed research international

2017年2017卷

6232616页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor.

BioMed research international

相似文献

BioMed research international

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor.

BioMed research international

相似文献

BioMed research international

相关期刊

检索历史清除